Beta-Lactamase Patterns and Beta-Lactam/Clavulanic Acid Resistance in Escherichia coli Isolated from Fecal Samples from Healthy Volunteers

REFERENCES

• Shanahan PMA, Thomson CJ, Amyes SGB. The global impact of antibiotic resistant bacteria: their sources and reser-voirs. Rev Med Microbiol 1994; 5: 174–82.
   Google Scholar
• Levy SB, Marshall B, Schluderberg S, Rowse D, Davis J. High frequency of antimicrobial resistance in human faecal flora. Antimicrob Agents Chemother 1988; 32: 1801–6.
   PubMed Web of Science ®Google Scholar
• Meares EM Jr. Nosocomial infectios of urinary tract, changing pathogens changing patterns. Urology 1985; 26 (1 Suppl): 2–4.
   PubMed Web of Science ®Google Scholar
• Shanahan PMA, Thomson CJ, Amyes SGB. b-lactam resistance in aerobic commensal faecal flora. Int J Antimicrob Agents 1994; 3: 259–66.
   PubMedGoogle Scholar
• Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995: 662–90.
   Google Scholar
• Cooksey R, Swenson J, Clark N, Gay E, Thornsberry C. Patterns and mechanism of β-lactam resistance among isolates of Escherichia coli from hospitals in the United States. Antimicrob Agents Chemother 1990; 34: 739–45.
   PubMed Web of Science ®Google Scholar
• Roy C, Foz A, Segura C, Tirado M, Fuster C, Reig R. Plasmid determined 13-lactamases identified in a group of 204 ampicillin resistant Enterobacteriaceae. J Antimicrob Chemother 1983; 12: 507–10.
   PubMed Web of Science ®Google Scholar
• Liu PYF, Cur D, Hall LMC, Livermore DM. Survey of the prevalence of β-lactamases amogst 1000 Gram-negative bacilli isolated consecutively at the Royal London Hospital. J Antimicrob Chemother 1992; 30: 429–47.
   PubMed Web of Science ®Google Scholar
• O'Shaughnessy EM, Fahle GA, Witebsky FG. Correlation of in vitro test results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli. J Clin Microbiol 1997; 35: 1902–3.
   PubMed Web of Science ®Google Scholar
• Henquell C, Chanal C, Sirot D, Labia R, Sirot J. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM 13-lactamases from clinicalisolates of Escherichia coli. Antimicrob Agents Chemother 1995; 39: 427–30.
   PubMed Web of Science ®Google Scholar
• Stapleton P, Wu PJ, King A, Shannon K, French G, Phillips I. Incidence and mechanisms of resistance tothe com-bination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob Agents Chemother 1995; 39: 2478–83.
   PubMed Web of Science ®Google Scholar
• Thomson CJ, Amyes SGB. TRC-1: emergence of a clavulanic acid-resistant TEM β-lactamase in a clinical strain. FEMS Microbiol Lett 1992; 91: 113–8.
   Web of Science ®Google Scholar
• Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn Jr WC, eds. Color atlas and textbook of diagnostic microbiology. 5th ed. New York: Lippincott, 1997: 196–200.
   Google Scholar
• National Committee for Clinical Laboratory Standarts. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically. Approved standart M7-A4. National Committee for Clinical Laboratory Standarts, Villanova, PA. 1997.
   Google Scholar
• National Committee for Clinical Laboratory Standarts. Performance standarts for antimicrobial disk susceptibility tests. Approved standart M2-A6. National Committee for Clinical Laboratory Standarts, Wayne, PA, 1997.
   Google Scholar
• Jarlier V, Nicholas MH, Fournier G, Phillippon A. Extended-broad spectrum beta-lactamases conferring transfer-able resistance to newer beta-lactam agents in Enterobacter-iaceae; hospital prevalance and susceptibility patterns. Rev Infect Dis 1988; 10: 867–78.
   PubMedGoogle Scholar
• Bachmann BJ. Pedigrees of some mutant strains of Escherichia coli. Bacteriol Rev 1972; 36: 525–57.
   PubMedGoogle Scholar
• Kado CI, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 1981; 145: 1365–73.
   PubMed Web of Science ®Google Scholar
• Nandivada LS, Amyes SGB. Plasmid-mediated b-lactam resistance in pathogenic Gram-negative bacteria isolated in South India. J Antimicrob Chemother 1990; 26: 279–90.
   PubMed Web of Science ®Google Scholar
• Matthew NI, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focusing for the detection and iden-tification of beta-lactamases. J Gen Microbiol 1975; 88: 169–178
   PubMedGoogle Scholar
• Waddell WJ, Hill C. A simple ultraviolet spectrophoto-metric method for the determination of protein. J Lab Clin Med 1956; 48: 311–3.
   PubMed Web of Science ®Google Scholar
• Payne DJ, Marriott MS, Amyes SGB. TEM-El: a novel beta-lactamase conferring resistance to ceftazidime. FEMS Microbiol Lett 1989; 50: 97–100.
   PubMed Web of Science ®Google Scholar
• Moorhouse EC. Transferable drug resistance in enter-°bacteria isolated from urban infants. Br Med J 1969; 2: 405–7.
   PubMed Web of Science ®Google Scholar
• Linton KB, Lee PA, Richmond MH et al. Antibiotic resistance and transmissible R-factors in the intestinal coliform flora of healthy adults and children in an urban and a rural community. J Hyg 1972; 70: 99–104.
   Google Scholar
• Bonten M, Stobberingh E, Phillips J, Houben A. High prevalance of antibiotic resistant Escherichia coli in faecal samples of students in the south-east of The Netherlands. J Antimicrob Chemother 1990; 26: 585–92.
   PubMed Web of Science ®Google Scholar
• Lester SC, del Pilar PM, Wang F, Perez SI, Jiang H, O'Brien TF. The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela and in Qin Pu, China. N Engl J Med 1990; 323: 285–9.
   PubMed Web of Science ®Google Scholar
• Amyes SGB, Tait S, Thomson CJ et al. The incidence of antibiotic resistance in aerobic faecal flora in South India. J Antimicrob Chemother 1992; 29: 415–25.
   Google Scholar
• Shanahan PMA, Wylie BA, Adrian PV, Koornhof HJ, Thomson CJ, Amyes SGB. The prevalance of antimicrobial resistance in human faecal flora in South Africa. Epidemiol Infect 1993; 111: 221–8.
   PubMed Web of Science ®Google Scholar
• Reguera JA, Baquero F, Pêrez-Diaz JC, Martinez JL. Factors determining resistance to β-lactam combined with 13-lactamase inhibitors in Escherichia coli. J Antimicrob Chemother 1991; 27: 569–75.
   PubMed Web of Science ®Google Scholar
• Wu PJ, Shannon K, Phillips I. Effect of hyperproduc-tion of TEM-1 β-lactamase on in vitro susceptibility of Escherichia coli to β-lactam antibiotics. Antimicrob Agents Chemother 1994; 38: 494–8.
   PubMed Web of Science ®Google Scholar
• Thomson K, Weber DA, Sanders CC, Sanders WEJr. β-lactamase production in members of the family Enterobacteriaceae and resistance to β-lactam-enzyme inhibitor combinations. Antimicrob Agents Chemother 1990; 34: 622–7.
   PubMed Web of Science ®Google Scholar
• Thou XY, Bordon F, Sirot D, Kitzis MD, Gutmann L. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resis-tance to β-lactamase inhibitors. Antimicrob Agents Chemother 1994; 38: 1085–9.
   PubMed Web of Science ®Google Scholar
• Blasquez J, Baquero MR, Canton R, Abs I, Baquero F. Characterization of a new TEM-type β-lactamase resistant to clavulnate, sulbactam and tazobactam in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother 1993; 37: 2059–63.
   PubMed Web of Science ®Google Scholar
• Oliver A, Pêrez-Vazquez M, Martinez-Ferrer M, Baquero F, De Rafael L, Canton R. Ampicillin-sulbactam and amoxycillin-clavulanate susceptibility testing of Escherichia coli isolates with different β-lactam resistance phenotypes. Antimicrob Agents Chemother 1999; 43: 862–7.
   PubMed Web of Science ®Google Scholar
• Vanjak D, Muller-Serieys C, Picard B, Bergogne-Berezin E, Lambert-Zechovsky N. Activity of beta-lactamase inhibitor combinations on Escerichia coli isolates exhibiting various patterns of resistance to beta-lactam agents. Eur J Clin Microbiol Infect Dis 1995; 14: 972–8.
   PubMed Web of Science ®Google Scholar
• Bush K, Jacoby GA, Mederios AA. A functional classifi-cation scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211–33.
   PubMed Web of Science ®Google Scholar
• Normark S, Lindquist S, Lindberg F. Chromosomal beta-lactam resistance in enterobacteria. Scand J Infect Dis 1986; 49: 38–45.
   Google Scholar
• Sawai T, Yamaguchi A, Hiruma R. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in Gram-nega-tive bacteria. Rev Infect Dis 1988; 10: 761–4.
   PubMedGoogle Scholar
• Stapleton PD, Shannon K, French GL. Carbapenem resistance in Escherichia coli associated with plasmid deter-mined CMY-4 β-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 1999; 43: 1206–10.
   PubMed Web of Science ®Google Scholar
• Nordmann P. Trends in β-lactam resistance among Enterobacteriaceae. Clin Infect Dis 1998; 27 (suppl1): S100-6.
   Google Scholar